Reuters: Deals: Morgan Stanley private equity buys $300 million stake in Tianhe Chem

Reuters: Deals Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Morgan Stanley private equity buys $300 million stake in Tianhe Chem Mar 21st 2012, 08:16 Tweet Share this Email Print Related News Goldman reviews conflict-of-interest policies Fri, Mar 16 2012 UPDATE 5-Petrochina-Ineos to let Morgan Stanley deal expire Wed, Mar 14 2012 China to be more creative with FX reserves: central bank Sun, Mar 11 2012 Exclusive: JPMorgan trumped competitors in commodities last year Fri, Mar 2 2012 Analysis & Opinion M&A lawyers lob stones at Goldman from glass house Essential tax and accounting reading: Targeting private equity taxes, IASB slows rate of change, struggling taxpayers get a break, California's stock option addiction, and more Related Topics Deals » Global Deals Review: 2011 Q3 » Global Deals Review: 2011 Q2 » Global Deals Review » The outside of the Morgan Stanley offices is seen in New York January 18, 2012. Credit: Reuters/Shannon Stapleton HONG KONG | Wed Mar 21, 2012 4:16am EDT HONG KONG (Reuters) - Morgan Stanley's (MS.N) Asia private equity arm has invested $300 million in China's Tianhe Chemicals Group, the two companies said on Wednesday, a deal that will help the company expand into U.S. and European markets. Morgan Stanley's private equity arm would take a minority stake in Tianhe Chemicals, according to a person familiar with the matter. As part of the deal, Homer Sun, the fund's chief investment officer, will join Tianhe's board. Morgan Stanley Private Equity Asia has invested about $2.4 billion in Asia, primarily in highly structured minority investments and control buyouts. Tianhe is the largest lubricant oil additive producer in China and a leading high-end specialty fluorochemical producer globally, the statement said. (Reporting by Stephen Aldred; Editing by Chris Lewis) Global Deals Review: 2011 Q3 Global Deals Review: 2011 Q2 Related Quotes and News Company Price Related News Tweet this Link this Share this Digg this Email Reprints We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/ Comments (0) Be the first to comment on reuters.com. Add yours using the box above.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions